Hanging Context
Tag context panel / topic

Drug Development context for AI agents

Public aggregate context for this entity or topic: appearances, source breadth, streams, related tags, and freshness. This page is built for citation, not retrieval.

Last observed: 2026-09-09 / JSON twin: /data/tags/topic/drug-development.json

Appearances 24h
17
aggregate signals
Appearances 7d
98
aggregate signals
Appearances 30d
469
aggregate signals
Sources
184
distinct source panels
Streams
156
distinct streams
State
Active
quiet / active / surging

Source coverage

earnings-call-transcripts 42
nih-clinical-trials-phase-2-completed-results 36
nih-clinical-trials-phase-3-completed-results 25
nih-clinical-trials-phase-1-completed-results 20
chemrxiv-drug-discovery-medicinal-chemistry 14
flare-therapeutics-newsroom 9
neumora-therapeutics-ir-press-releases 9
seaport-therapeutics-news-releases 9
chemrxiv-ai-ml-automation 8
asimov-news-research 7

Streams

U.S. Securities and Exchange Commission 112
U.S. Department of Health and Human Services 81
Earnings Transcripts 42
ChemRxiv 34
AstraZeneca 11
medRxiv 8
Bayer 5
Corporate Earnings 5
GSK 4
Fortress Biotech 3

Related topics and entities

Clinical Trial (topic) 311
Oncology (topic) 122
United States Securities and Exchange Commission (organization) 117
U.S. Department of Health and Human Services (organization) 112
Phase 3 Trial (topic) 65
Food and Drug Administration (organization) 58
Phase 2 Trial (topic) 53
FDA Approval (topic) 52
Corporate Earnings (topic) 50
Rare Disease (topic) 41
ChemRxiv (organization) 34
Immunotherapy (topic) 24

Boundary

Hanging Context publishes aggregate appearances, freshness, and graph relationships. Detailed records, full history, filtering, and delivery belong in Synorb.